Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pepsinogens in gastric carcinomas.

R M Busby-Earle, A R Williams, J Piris

    Human Pathology
    |October 1, 1986
    PubMed
    Summary

    This study investigated pepsinogens (PG I and PG II) in human gastric carcinomas. Pepsinogen presence in tumor cells was observed, but not linked to specific Lauren classifications, suggesting a common origin for diffuse and intestinal types.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Intrauterine growth restriction in piglets modulates postnatal immune function and hepatic transcriptional responses independently of energy intake.

    Frontiers in physiology·2023
    Same author

    An increased weaning age and liquid feed enhances weight gain compared to piglets fed dry feed pre-weaning.

    Animal : an international journal of animal bioscience·2023
    Same author

    Modulation of human dendritic cell activity by Giardia and helminth antigens.

    Parasite immunology·2018
    Same author

    Mind the gaps in research on the control of gastrointestinal nematodes of farmed ruminants and pigs.

    Transboundary and emerging diseases·2017
    Same author

    Mucosal and systemic immune modulation by Trichuris trichiura in a self-infected individual.

    Parasite immunology·2016
    Same author

    Transition from paediatric surgery: how many patients do we need to plan for?

    Annals of the Royal College of Surgeons of England·2016

    Area of Science:

    • Gastroenterology
    • Oncology
    • Immunohistochemistry

    Background:

    • Human gastric carcinomas are classified into diffuse and intestinal types by the Lauren classification.
    • Pepsinogens (PG I and PG II) are key enzymes in the stomach, and their presence in tumors is of interest.
    • Understanding the cellular origins and markers of gastric cancer subtypes is crucial for diagnosis and treatment.

    Purpose of the Study:

    • To investigate the expression of pepsinogen I (PG I) and pepsinogen II (PG II) in human gastric carcinomas.
    • To determine if pepsinogen expression correlates with the Lauren classification (diffuse vs. intestinal) of gastric tumors.
    • To explore the potential implications of pepsinogen presence in tumor cells for gastric carcinoma histogenesis.

    Main Methods:

    • Immunohistochemical analysis using polyclonal rabbit antisera against PG I and PG II.
    • Study of 32 human gastric carcinomas, classified according to the Lauren system.
    • Assessment of pepsinogen staining patterns in both neoplastic cells and adjacent gastric mucosa.

    Main Results:

    • Pepsinogen I and/or PG II staining was detected in neoplastic cells of some gastric carcinomas of both diffuse and intestinal types.
    • PG I was found more frequently than PG II in the studied tumors.
    • No characteristic pepsinogen staining pattern was associated with either the diffuse or intestinal Lauren type of gastric carcinoma.

    Conclusions:

    • The presence of pepsinogens in gastric carcinoma cells does not appear to be a distinguishing feature related to the Lauren classification.
    • These findings do not support a distinct histogenetic origin for the diffuse and intestinal types of gastric carcinoma.
    • Pepsinogen expression may offer insights into cellular differentiation but does not differentiate between major gastric cancer subtypes.

    Related Experiment Videos